Prestige Diagnostics: In Vitro Diagnostic Medical Devices

Having attended DPC23 showcasing a wonderfully simple HbA1c point of care analyser, it really brought home to us the desire of people working on the front lines of primary care to be able to offer their patients timely information and diagnosis in an easy and straight forward manner.

Our background is in manufacturing IVD reagents and distributing laboratory equipment. Our MD and proprietor, who previously worked for some large diagnostic companies as an engineer, has a knack for spotting well designed machines, from talented manufactures. Since 2020, our business has expanded, including offering a suite POCT equipment from several well renowned and innovative IVD tech companies.

From the clinicians’ point of view, having a simple system using easy sampling methods that gives reliable results within minutes has huge advantages. Having the information at hand quickly, can help them guide the patient towards the most appropriate care pathway very efficiently and improve early detection rates. It can also have the benefit of reducing unnecessary hospital admissions and even reduce overprescription of antibiotics.

From the patient’s perspective, getting results quickly from a ‘finger prick’ blood sample, is much less stressful, not to mention if the referral process is more direct, it will greatly improve their experience.

Naturally, when trying to introduce new platforms into the healthcare system, there are some obstacles, but with the increasing amount of decentralised primary care settings there is an increasing opportunity to deliver testing widely that can really make a difference. As the mantra goes, it’s the right test, in the right place, at the right time.

People are also engaging more in their own wellbeing, if it’s easy, affordable, and accessible, there is huge potential to reduce preventative illness; the HbA1c test is the perfect example. Giving people knowledge, can empower them to make simple lifestyle changes that can reduce developing serious illness. This manifested itself amongst our own staff who, after taking the test, have largely had a significant reduction in their levels of HbA1c.

The vision is to give people the tools to seek the support and care pathways required. With advances in POCT technologies, we are now offering systems for haematology, biochemistry, CLIA, and PCR that provide simple, yet sophisticated (not to mention intelligent with the advances in AI), clinical diagnostic platforms that are not only up to the standards of laboratory testing but can be applied virtually anywhere.

Please contactT +44 (0)28 2564 2100 info@prestigediagnostics.co.ukwww.prestigediagnostics.co.uk